News
HC Wainwright & Co. Reiterates Buy on Regulus Therapeutics, Maintains $9 Price Target
25 Mar 24
News, Price Target, Reiteration, Analyst Ratings
Regulus Therapeutics Q4 EPS $(0.40) Misses $(0.39) Estimate
21 Mar 24
Earnings, News
Canaccord Genuity Maintains Buy on Regulus Therapeutics, Lowers Price Target to $11
19 Mar 24
News, Price Target, Analyst Ratings
Leerink Partners Initiates Coverage On Regulus Therapeutics with Outperform Rating, Announces Price Target of $6
18 Mar 24
News, Price Target, Initiation, Analyst Ratings
Why Limbach Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
14 Mar 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Wells Fargo Maintains Equal-Weight on Regulus Therapeutics, Raises Price Target to $3
13 Mar 24
News, Price Target, Analyst Ratings
Gold Down Over 1%; ClearOne Shares Spike Higher
12 Mar 24
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets, Trading Ideas
Why Asana Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
12 Mar 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
12 Health Care Stocks Moving In Tuesday's Intraday Session
12 Mar 24
Movers
Nasdaq Surges Over 1%; Blade Air Mobility Shares Plummet
12 Mar 24
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets, Trading Ideas
Dow Gains 100 Points; US Inflation Rate Rises To 3.2% In February
12 Mar 24
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets, Trading Ideas
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
12 Mar 24
Movers
Market-Moving News for March 12th
12 Mar 24
Movers, Trading Ideas
Why Is Kidney Disease-Focused Regulus Therapeutics Stock Trading Higher On Tuesday?
12 Mar 24
Biotech, Equities, News, Health Care, Financing, Offerings, Movers, Trading Ideas, General
Regulus Therapeutics Released Topline Data From The Second Cohort Of Patients In Its Phase 1b Multiple-Ascending Dose Trial Of RGLS8429 For Autosomal Dominant Polycystic Kidney Disease
12 Mar 24
Biotech, News, Health Care, General
Press releases
Regulus Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Updates
21 Mar 24
Earnings, Press Releases
Emerging Companies: Key Developments and Investment Insights RGLS, INBS, VTAK, DYAI, TCBP
13 Mar 24
News, Press Releases
Thinking about buying stock in BigBear.ai, Nukkleus, Singularity Future Technology, Regulus Therapeutics, or ATRenew?
12 Mar 24
Small Cap, Opinion, Press Releases
Regulus Therapeutics Announces Oversubscribed $100 Million Private Placement of Equity
12 Mar 24
Press Releases
Regulus Therapeutics Announces Positive Topline Data from the Second Cohort of Patients in its Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of RGLS8429 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
12 Mar 24
Press Releases